You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 451 Serum albumin predicts outcome in patients with extensive stage small-cell lung cancer (ES-SCLC) receiving first-line combination of PD-(L)1 inhibitors and platinum-etoposide chemotherapy

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
451 Serum albumin predicts outcome in patients with extensive stage small-cell lung cancer (ES-SCLC) receiving first-line combination of PD-(L)1 inhibitors and platinum-etoposide chemotherapy
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to September 2024

AbstractFullPdf
Nov 2022154024
Dec 20226104
Jan 20234006
Feb 20235204
Mar 20233005
Apr 20232805
May 20233705
Jun 20234204
Jul 20233105
Aug 20232001
Sep 20231604
Oct 20237306
Nov 20234003
Dec 20234204
Jan 20242203
Feb 20242405
Mar 20243805
Apr 20242508
May 20242801
Jun 20242104
Jul 20242803
Aug 20242704
Sep 20242902
Total9080115